在MeV质子束下用金属纳米粒子进行放射敏感化:局部剂量增强
Elham Mansouri1, Ghada Almisned2, H O Tekin3,4,5
1Medical Radiation Research Team, 84 Gorge Road, South Morang, Melbourne, 3752, Australia.
Radiation and environmental biophysics
|August 16, 2024
概括
金属纳米粒子通过增加纳米尺度的剂量沉积来增强质子疗法. 这项研究量化了纳米粒子辐射敏感性,显示了较高质子能量的提高剂量优势.
科学领域:
- 医学物理 医学物理
- 纳米技术纳米技术
- 辐射瘤学 辐射瘤学
背景情况:
- 质子疗法比X射线和玛辐射具有更高的生物学效果.
- 金属纳米颗粒被研究为放射敏感剂,以提高瘤治疗效率.
- 之前的研究探讨了质子疗法中的纳米粒子疗效,需要详细的纳米镜剂量分析.
研究的目的:
- 用质子束在水中量化金属纳米粒子 (黄金,,,加多) 的纳米剂量沉积增强.
- 分析剂量增强因子,辐射剂量分布和纳米级的二次粒子光谱.
- 评估不同质子能量 (5,25,50 MeV) 对纳米粒子辐射敏感化的影响.
主要方法:
- 使用Geant4蒙特卡罗 (MC) 代码进行精确的纳米模拟.
- 计算了50纳米金属纳米粒子的剂量增强因子和辐射剂量分布.
- 模拟了5,25和50 MeV质子与纳米粒子合水的相互作用.
主要成果:
- 金属纳米粒子在质子辐射下显著增加纳米尺度的剂量沉积.
- 增加的质子能量 (5-50 MeV) 导致二次电子和光子生产产量下降.
- 辐射剂量增强因子随着质子能量的增加,从1.4增加到16.
结论:
- 金属纳米粒子可以显著提高质子疗法的剂量学优势.
- 质子束和金属纳米粒子的组合为增强辐射瘤学提供了一个有前途的战略.
- 在质子疗法中对基于纳米粒子的放射敏感性进行进一步的研究是有必要的.
相关概念视频
03:20Nuclear Transmutation
Nuclear transmutation is the conversion of one nuclide into another. It can occur by the radioactive decay of a nucleus, or the reaction of a nucleus with another particle. The first manmade nucleus was produced in Ernest Rutherford’s laboratory in 1919 by a transmutation reaction, the bombardment of one type of nuclei with other nuclei or with neutrons. Rutherford bombarded nitrogen-14 atoms with high-speed α particles from a natural radioactive isotope of radium and observed protons being...
01:14Diamagnetic Shielding of Nuclei: Local Diamagnetic Current
An applied magnetic field causes the electrons present in the molecule to circulate, setting up a local diamagnetic current within the molecule. The local diamagnetic current arising from circulating sigma-bonding electrons induces a magnetic field, Blocal that opposes the applied magnetic field, B0. The effective magnetic field experienced by these nuclei is given by the difference between the applied and local magnetic fields in a phenomenon called local diamagnetic shielding. Essentially,...
01:20Immunogold Electron Microscopy
Immunoelectron microscopy utilizes immunogold labeling of endogenous proteins with specific antibodies to detect and localize these proteins in cells and tissues. The procedure provides insights into the distribution and quantification of protein under different stimulation conditions offering clues about their functions. Conjugating highly electron-dense gold particles with primary or secondary antibodies allow antigen detection on and within cells, with high resolution and specificity.